ANGELES WEALTH MANAGEMENT, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1929170
SANTA MONICA, CA
Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$747,932
-$79,368 QoQ
Shares Held
5,920
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,207
of 2,266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ANGELES WEALTH MANAGEMENT, LLC holds $30,855,204 across 12 Drug Manufacturers - General names. GILD ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,926 | $9,506,682 | |
| 2 | ABBV |
AbbVie Inc.
|
23,439 | $5,898,189 | |
| 3 | JNJ |
Johnson & Johnson
|
20,743 | $5,268,099 | |
| 4 | MRK |
Merck & Co., Inc.
|
37,088 | $4,765,808 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,763 | $1,196,364 | |
| 6 | AMGN |
Amgen Inc
|
2,304 | $834,324 | |
| 7 | NVO |
Novo Nordisk A S
|
16,884 | $809,418 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
5,920 | $747,932 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $747,932 | 5,920 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $827,300 | 5,936 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $514,526 | 4,192 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $426,129 | 3,839 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $438,379 | 3,954 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $261,860 | 2,337 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $200,258 | 2,168 | Shares | Sole | 2025-01-28 | |
| No filing history on record for this holder in this stock. | ||||||